Jonathan L. Bramson

9.3k total citations
176 papers, 6.8k citations indexed

About

Jonathan L. Bramson is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Jonathan L. Bramson has authored 176 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Immunology, 69 papers in Oncology and 47 papers in Molecular Biology. Recurrent topics in Jonathan L. Bramson's work include Immunotherapy and Immune Responses (60 papers), CAR-T cell therapy research (54 papers) and Immune Cell Function and Interaction (45 papers). Jonathan L. Bramson is often cited by papers focused on Immunotherapy and Immune Responses (60 papers), CAR-T cell therapy research (54 papers) and Immune Cell Function and Interaction (45 papers). Jonathan L. Bramson collaborates with scholars based in Canada, United States and Australia. Jonathan L. Bramson's co-authors include Yonghong Wan, Jack Gauldie, David J. D. Earn, Frank L. Graham, Raluca Eftimie, Mary Hitt, Mark Loeb, Brian D. Lichty, Byram W. Bridle and Alina Lelic and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Jonathan L. Bramson

171 papers receiving 6.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan L. Bramson Canada 47 3.2k 2.4k 2.2k 1.8k 978 176 6.8k
Burkhard Ludewig Switzerland 60 7.4k 2.3× 2.3k 1.0× 2.8k 1.3× 634 0.4× 1.5k 1.6× 209 11.4k
Anne Kelso Australia 54 5.5k 1.7× 1.4k 0.6× 2.2k 1.0× 730 0.4× 756 0.8× 165 9.4k
Andrea Gambotto United States 46 2.9k 0.9× 1.3k 0.5× 2.3k 1.0× 1.3k 0.8× 1.1k 1.2× 115 6.3k
Bo‐Jian Zheng Hong Kong 49 2.0k 0.6× 1.5k 0.6× 2.2k 1.0× 876 0.5× 4.5k 4.6× 121 9.4k
Philip D. Hodgkin Australia 52 8.0k 2.5× 1.4k 0.6× 2.5k 1.2× 568 0.3× 425 0.4× 157 10.9k
Mark J. Cameron United States 40 2.7k 0.8× 834 0.3× 1.2k 0.6× 738 0.4× 1.1k 1.1× 137 5.4k
Filippo Belardelli Italy 61 10.0k 3.1× 4.4k 1.8× 3.1k 1.4× 956 0.5× 1.3k 1.3× 258 14.9k
Scott D. Boyd United States 41 3.2k 1.0× 1.1k 0.4× 2.2k 1.0× 421 0.2× 702 0.7× 119 6.7k
David J. Topham United States 54 6.0k 1.9× 2.3k 1.0× 2.4k 1.1× 611 0.3× 1.4k 1.4× 180 10.9k
David F. Tough United Kingdom 53 9.7k 3.0× 2.0k 0.8× 2.5k 1.2× 759 0.4× 994 1.0× 107 12.7k

Countries citing papers authored by Jonathan L. Bramson

Since Specialization
Citations

This map shows the geographic impact of Jonathan L. Bramson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan L. Bramson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan L. Bramson more than expected).

Fields of papers citing papers by Jonathan L. Bramson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan L. Bramson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan L. Bramson. The network helps show where Jonathan L. Bramson may publish in the future.

Co-authorship network of co-authors of Jonathan L. Bramson

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan L. Bramson. A scholar is included among the top collaborators of Jonathan L. Bramson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan L. Bramson. Jonathan L. Bramson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tsakiridis, Evangelia E., Elham Ahmadi, Jianhan Wu, et al.. (2023). Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non‐small cell lung cancer (NSCLC) through inhibition of HIF‐1α. Molecular Oncology. 17(11). 2235–2256. 17 indexed citations
3.
Nguyen, Andrew, Ramya Krishnan, Donald Bastin, et al.. (2023). HDACi-dependent Microenvironmental Normalization Overcomes Tumor Burden–induced T-cell Exhaustion. Clinical Cancer Research. 29(20). 4289–4305. 2 indexed citations
4.
Huynh, Angela, Ali Zhang, Hannah D. Stacey, et al.. (2022). Cytomegalovirus Seropositivity in Older Adults Changes the T Cell Repertoire but Does Not Prevent Antibody or Cellular Responses to SARS-CoV-2 Vaccination. The Journal of Immunology. 209(10). 1892–1905. 10 indexed citations
5.
Janelle, Valérie, et al.. (2019). TGFβ Programs Central Memory Differentiation in Ex Vivo –Stimulated Human T Cells. Cancer Immunology Research. 7(9). 1426–1439. 17 indexed citations
6.
Poznanski, Sophie M., Tina Nham, Marianne V. Chew, et al.. (2018). Expanded CD56superbrightCD16+ NK Cells from Ovarian Cancer Patients Are Cytotoxic against Autologous Tumor in a Patient-Derived Xenograft Murine Model. Cancer Immunology Research. 6(10). 1174–1185. 43 indexed citations
7.
Helsen, Christopher W., Joanne A. Hammill, Vivian Wing Chong Lau, et al.. (2018). The chimeric TAC receptor co-opts the T cell receptor yielding robust anti-tumor activity without toxicity. Nature Communications. 9(1). 3049–3049. 106 indexed citations
8.
Bridle, Byram W., Jian Li, Shucui Jiang, et al.. (2010). Immunotherapy Can Reject Intracranial Tumor Cells without Damaging the Brain despite Sharing the Target Antigen. The Journal of Immunology. 184(8). 4269–4275. 13 indexed citations
9.
Grinshtein, Natalie, Byram W. Bridle, Yonghong Wan, & Jonathan L. Bramson. (2009). Neoadjuvant Vaccination Provides Superior Protection against Tumor Relapse following Surgery Compared with Adjuvant Vaccination. Cancer Research. 69(9). 3979–3985. 24 indexed citations
10.
Parsons, Robin, Alina Lelic, Lisa Hayes, et al.. (2008). The Memory T Cell Response to West Nile Virus in Symptomatic Humans following Natural Infection Is Not Influenced by Age and Is Dominated by a Restricted Set of CD8+ T Cell Epitopes. The Journal of Immunology. 181(2). 1563–1572. 27 indexed citations
11.
12.
Yang, Ping‐Chang, et al.. (2007). Antigen Presentation by Exosomes Released from Peptide-Pulsed Dendritic Cells Is not Suppressed by the Presence of Active CTL. The Journal of Immunology. 179(8). 5024–5032. 113 indexed citations
13.
Divangahi, Maziar, Kapilan Kugathasan, Sarah McCormick, et al.. (2007). Critical Negative Regulation of Type 1 T Cell Immunity and Immunopathology by Signaling Adaptor DAP12 during Intracellular Infection. The Journal of Immunology. 179(6). 4015–4026. 34 indexed citations
14.
Álvarez, David, Filip K. Świrski, Ramzi Fattouh, et al.. (2006). Inhalation Tolerance Is Induced Selectively in Thoracic Lymph Nodes but Executed Pervasively at Distant Mucosal and Nonmucosal Tissues. The Journal of Immunology. 176(4). 2568–2580. 16 indexed citations
15.
Millar, James, Natalie Grinshtein, Robin Parsons, et al.. (2006). The CD8+ T Cell Population Elicited by Recombinant Adenovirus Displays a Novel Partially Exhausted Phenotype Associated with Prolonged Antigen Presentation That Nonetheless Provides Long-Term Immunity. The Journal of Immunology. 176(1). 200–210. 76 indexed citations
16.
Álvarez, David, Ramzi Fattouh, Jiangfeng Sun, et al.. (2005). Cutaneous Antigen Priming via Gene Gun Leads to Skin-Selective Th2 Immune-Inflammatory Responses. The Journal of Immunology. 174(3). 1664–1674. 29 indexed citations
17.
Zganiacz, Anna, Michael Santosuosso, Jun Wang, et al.. (2004). TNF-α is a critical negative regulator of type 1 immune activation during intracellular bacterial infection. Journal of Clinical Investigation. 113(3). 401–413. 170 indexed citations
18.
Bertram, Edward M., Wojciech Dawicki, Bradley J. Sedgmen, et al.. (2004). A Switch in Costimulation from CD28 to 4-1BB during Primary versus Secondary CD8 T Cell Response to Influenza In Vivo. The Journal of Immunology. 172(2). 981–988. 107 indexed citations
19.
Millar, James, et al.. (2003). Electroporation Enables Plasmid Vaccines to Elicit CD8+ T Cell Responses in the Absence of CD4+ T Cells. The Journal of Immunology. 171(7). 3379–3384. 32 indexed citations
20.
Wan, Yonghong, Л. Лу, Jonathan L. Bramson, et al.. (2001). Dendritic Cell-Derived IL-12 Is Not Required for the Generation of Cytotoxic, IFN-γ-Secreting, CD8+ CTL In Vivo. The Journal of Immunology. 167(9). 5027–5033. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Burkhard Ludewig Breakdown of academic impact, for papers by Anne Kelso Breakdown of academic impact, for papers by Andrea Gambotto Breakdown of academic impact, for papers by Bo‐Jian Zheng Breakdown of academic impact, for papers by Philip D. Hodgkin Breakdown of academic impact, for papers by Mark J. Cameron Breakdown of academic impact, for papers by Filippo Belardelli Breakdown of academic impact, for papers by Scott D. Boyd Breakdown of academic impact, for papers by David J. Topham Breakdown of academic impact, for papers by David F. Tough
Rankless by CCL
2026